Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions

Abraham JE, Guo Q, Dorling L, Tyrer J, Ingle S, Hardy R, Vallier AL, Hiller L, Burns R, Jones L, Bowden SJ, Dunn JA, Poole CJ, Caldas C, Pharoah PP, Earl HM (2014) Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with paclitaxel. Clin Cancer Res 20(9):2466–2475. https://doi.org/10.1158/1078-0432.CCR-13-3232

CAS  CrossRef  PubMed  Google Scholar 

Albers JW, Chaudhry V, Cavaletti G, Donehower RC (2014) Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev 3(3):CD005228. https://doi.org/10.1002/14651858.CD005228.pub4

CrossRef  Google Scholar 

Anderson JT, Hu S, Fu Q, Baker SD, Sparreboom A (2019) Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice. Pharmacol Res Perspect 7(6):e00534. https://doi.org/10.1002/prp2.534

CrossRef  PubMed  PubMed Central  Google Scholar 

Andreev E, Brosseau N, Carmona E, Mes-Masson AM, Ramotar D (2016) The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin. Sci Rep 6:20508. https://doi.org/10.1038/srep20508

CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23(5):460–464

CAS  CrossRef  Google Scholar 

Argyriou AA, Polychronopoulos P, Iconomou G, Chroni E, Kalofonos HP (2008) A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat Rev 34(4):368–377. https://doi.org/10.1016/j.ctrv.2008.01.003

CAS  CrossRef  PubMed  Google Scholar 

Argyriou AA, Cavaletti G, Briani C, Velasco R, Bruna J, Campagnolo M, Alberti P, Bergamo F, Cortinovis D, Cazzaniga M, Santos C, Papadimitriou K, Kalofonos HP (2013) Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer 119(2):438–444. https://doi.org/10.1002/cncr.27732

CAS  CrossRef  PubMed  Google Scholar 

Atilano-Roque A, Joy MS (2017) Characterization of simvastatin acid uptake by organic anion transporting polypeptide 3A1 (OATP3A1) and influence of drug-drug interaction. Toxicol In Vitro 45(Pt 1):158–165. https://doi.org/10.1016/j.tiv.2017.09.002

CAS  CrossRef  PubMed  Google Scholar 

Ayala-Lopez N, Jackson WF, Burnett R, Wilson JN, Thompson JM, Watts SW (2015) Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue. Am J Physiol Heart Circ Physiol 309(11):H1904–H1914. https://doi.org/10.1152/ajpheart.00308.2015

CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

Ayla S, Seckin I, Tanriverdi G, Cengiz M, Eser M, Soner BC, Oktem G (2011) Doxorubicin induced nephrotoxicity: protective effect of nicotinamide. Int J Cell Biol 2011:390238. https://doi.org/10.1155/2011/390238

CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

Bachmakov I, Glaeser H, Endress B, Morl F, Konig J, Fromm MF (2009) Interaction of beta-blockers with the renal uptake transporter OCT2. Diabetes Obes Metab 11(11):1080–1083. https://doi.org/10.1111/j.1463-1326.2009.01076.x

CAS  CrossRef  PubMed  Google Scholar 

Baker SD, Verweij J, Cusatis GA, van Schaik RH, Marsh S, Orwick SJ, Franke RM, Hu S, Schuetz EG, Lamba V, Messersmith WA, Wolff AC, Carducci MA, Sparreboom A (2009) Pharmacogenetic pathway analysis of docetaxel elimination. Clin Pharmacol Ther 85(2):155–163. https://doi.org/10.1038/clpt.2008.95

CAS  CrossRef  PubMed  Google Scholar 

Baldwin SA, Mackey JR, Cass CE, Young JD (1999) Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 5(5):216–224. https://doi.org/10.1016/S1357-4310(99)01459-8

CAS  CrossRef  PubMed  Google Scholar 

Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL (2012) A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res 18(18):5099–5109. https://doi.org/10.1158/1078-0432.CCR-12-1590

CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

Ban M, Hettich D, Huguet N (1994) Nephrotoxicity mechanism of cis-platinum (II) diamine dichloride in mice. Toxicol Lett 71(2):161–168

CAS  CrossRef  Google Scholar 

Belum VR, Wu S, Lacouture ME (2013) Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysis. Investig New Drugs 31(4):1078–1086. https://doi.org/10.1007/s10637-013-9977-0

CAS  CrossRef  Google Scholar 

Bergmann TK, Vach W, Feddersen S, Eckhoff L, Green H, Herrstedt J, Brosen K (2013) GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients. Acta Oncol 52(4):871–874. https://doi.org/10.3109/0284186X.2012.707787

CAS  CrossRef  PubMed  Google Scholar 

Berns JS, Ford PA (1997) Renal toxicities of antineoplastic drugs and bone marrow transplantation. Semin Nephrol 17(1):54–66

CAS  PubMed  Google Scholar 

Boehmerle W, Huehnchen P, Peruzzaro S, Balkaya M, Endres M (2014) Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice. Sci Rep 4:6370. https://doi.org/10.1038/srep06370

CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

Boora GK, Kanwar R, Kulkarni AA, Abyzov A, Sloan J, Ruddy KJ, Banck MS, Loprinzi CL, Beutler AS (2016) Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance). Cancer Med 5(4):631–639. https://doi.org/10.1002/cam4.625

CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

Borst P, Elferink RO (2002) Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537–592. https://doi.org/10.1146/annurev.biochem.71.102301.093055

CAS  CrossRef  PubMed  Google Scholar 

Borst P, Evers R, Kool M, Wijnholds J (2000) A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92(16):1295–1302

CAS  CrossRef  Google Scholar 

Botchkarev VA, Paus R (2003) Molecular biology of hair morphogenesis: development and cycling. J Exp Zool B Mol Dev Evol 298(1):164–180. https://doi.org/10.1002/jez.b.33

CrossRef  PubMed  Google Scholar 

Boucek RJ Jr, Dodd DA, Atkinson JB, Oquist N, Olson RD (1997) Contractile failure in chronic doxorubicin-induced cardiomyopathy. J Mol Cell Cardiol 29(10):2631–2640

CAS  CrossRef  Google Scholar 

Brewer JR, Morrison G, Dolan ME, Fleming GF (2016) Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol 140(1):176–183. https://doi.org/10.1016/j.ygyno.2015.11.011

CAS  CrossRef  PubMed  Google Scholar 

Bronchud MH, Margison JM, Howell A, Lind M, Lucas SB, Wilkinson PM (1990) Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer. Cancer Chemother Pharmacol 25(6):435–439. https://doi.org/10.1007/bf00686055

CAS  CrossRef  PubMed  Google Scholar 

Brosseau N, Andreev E, Ramotar D (2015) Complementation of the yeast model system reveals that Caenorhabditis elegans OCT-1 is a functional transporter of anthracyclines. PLoS One 10(7):e0133182. https://doi.org/10.1371/journal.pone.0133182

CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

Carozzi VA, Canta A, Chiorazzi A (2015) Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms? Neurosci Lett 596:90–107. https://doi.org/10.1016/j.neulet.2014.10.014

CAS  CrossRef  PubMed  Google Scholar 

Caterson R, Etheredge S, Snitch P, Duggin G (1983) Mechanisms of renal excretion of cisdichlorodiamine platinum. Res Commun Chem Pathol Pharmacol 41(2):255–264

CAS  PubMed  Google Scholar 

Cavaletti G, Cavalletti E, Oggioni N, Sottani C, Minoia C, D’Incalci M, Zucchetti M, Marmiroli P, Tredici G (2000) Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration. Neurotoxicology 21(3):389–393

CAS  PubMed  Google Scholar 

Cavaletti G, Tredici G, Petruccioli MG, Donde E, Tredici P, Marmiroli P, Minoia C, Ronchi A, Bayssas M, Etienne GG (2001) Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer 37(18):2457–2463. https://doi.org/10.1016/s0959-8049(01)00300-8

CAS  CrossRef  PubMed  Google Scholar 

Chae YK, Arya A, Malecek MK, Shin DS, Carneiro B, Chandra S, Kaplan J, Kalyan A, Altman JK, Platanias L, Giles F (2016) Repurposing metformin for cancer treatment: current clinical studies. Oncotarget 7(26):40767–40780. https://doi.org/10.18632/oncotarget.8194

CrossRef  PubMed  PubMed Central  Google Scholar 

Chen M, Neul C, Schaeffeler E, Frisch F, Winter S, Schwab M, Koepsell H, Hu S, Laufer S, Baker SD, Sparreboom A, Nies AT (2020) Sorafenib activity and disposition in liver cancer does not depend on organic cation transporter 1. Clin Pharmacol Ther 107(1):227–237. https://doi.org/10.1002/cpt.1588

CAS  CrossRef  PubMed  Google Scholar 

Chester JD, Joel SP, Cheeseman SL, Hall GD, Braun MS, Perry J, Davis T, Button CJ, Seymour MT (2003) Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fuorouracil-refractory metastatic colon cancer. J Clin Oncol 21(6):1125–1132. https://doi.org/10.1200/JCO.2003.08.049

CAS  CrossRef  PubMed  Google Scholar 

Cho SK, Chung JY (2016) The MATE1 rs2289669 polymorphism affects the renal clearance of metformin following ranitidine treatment. Int J Clin Pharmacol Ther 54(4):253–262. https://doi.org/10.5414/CP202473

CAS  CrossRef  PubMed  Google Scholar 

Cho SK, Kim CO, Park ES, Chung JY (2014) Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers. Br J Clin Pharmacol 78(6):1426–1432. https://doi.org/10.1111/bcp.12476

CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif